Resistance of HIV-1 reverse transcriptase against [2',5'-bis-O-(tert-butyldimethylsilyl)-3'-spiro-5''-(4''-amino-1'',2''- oxathiole-2'',2''-dioxide)] (TSAO) derivatives is determined by the mutation Glu138-->Lys on the p51 subunit. [electronic resource]
- The Journal of biological chemistry Oct 1994
- 25255-8 p. digital
Publication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't
0021-9258
Antiviral Agents--chemistry Base Sequence Benzodiazepines--pharmacology Binding Sites--genetics Deoxyguanine Nucleotides--pharmacology Dideoxynucleotides Drug Resistance--genetics Escherichia coli--genetics HIV Reverse Transcriptase Imidazoles--pharmacology Molecular Sequence Data Mutagenesis, Site-Directed Mutation Protein Conformation RNA-Directed DNA Polymerase--genetics Recombinant Proteins--metabolism Reverse Transcriptase Inhibitors Sequence Analysis, DNA Spiro Compounds Thymidine--analogs & derivatives Uridine--analogs & derivatives